Global Pharmaceutical CDMO Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Pharmaceutical CDMO market size was valued at US$ 125480 million in 2023. With growing demand in downstream market, the Pharmaceutical CDMO is forecast to a readjusted size of US$ 214600 million by 2030 with a CAGR of 8.0% during review period.
The research report highlights the growth potential of the global Pharmaceutical CDMO market. Pharmaceutical CDMO are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pharmaceutical CDMO. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pharmaceutical CDMO market.
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
Contract Pharmaceutical Manufacturing is part of CDMO, refers to accept commissioned from pharmaceutical companies, provide the service about API production, FDF production, packaging.
Pharmaceutical companies are likely to outsource a wide range of manufacturing related activities including – primary and secondary packaging, formulation, active ingredient manufacturing, labeling, clinical supplies, sterilization, manufacturing of chemical intermediates, etc. CDMOs support pharmaceutical companies at all stages of the process of making medicines: by providing services in the research and development stages, by offering support in manufacturing, and by providing formulating and finishing processes.
The key service providers of the Pharmaceutical CDMO in the world are Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics and Siegfried, among which the market share of the top three service providers exceeds 10%, and Lonza is the largest service provider. The services provided by global pharmaceutical CDMO are mainly distributed in North America, Europe and China, among which the top three regions account for nearly 60% of the market share, and North America is currently the largest service provider. In terms of its service type, the growth rate of FDF CDMO is relatively fast. At present, the market share of API CDMO is the highest, more than 40%, followed by FDF CDMO, packaging CDMO and clinical CDMO. In terms of its application, pharmaceutical company are the largest application field, with a market share of more than 60%, followed by biotechnology company.
Key Features:
The report on Pharmaceutical CDMO market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pharmaceutical CDMO market. It may include historical data, market segmentation by Type (e.g., API CDMO, FDF CDMO), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pharmaceutical CDMO market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pharmaceutical CDMO market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pharmaceutical CDMO industry. This include advancements in Pharmaceutical CDMO technology, Pharmaceutical CDMO new entrants, Pharmaceutical CDMO new investment, and other innovations that are shaping the future of Pharmaceutical CDMO.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pharmaceutical CDMO market. It includes factors influencing customer ' purchasing decisions, preferences for Pharmaceutical CDMO product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pharmaceutical CDMO market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pharmaceutical CDMO market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pharmaceutical CDMO market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pharmaceutical CDMO industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pharmaceutical CDMO market.
Market Segmentation:
Pharmaceutical CDMO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Pharmaceutical CDMO market size was valued at US$ 125480 million in 2023. With growing demand in downstream market, the Pharmaceutical CDMO is forecast to a readjusted size of US$ 214600 million by 2030 with a CAGR of 8.0% during review period.
The research report highlights the growth potential of the global Pharmaceutical CDMO market. Pharmaceutical CDMO are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pharmaceutical CDMO. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pharmaceutical CDMO market.
A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fields: product development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
Contract Pharmaceutical Manufacturing is part of CDMO, refers to accept commissioned from pharmaceutical companies, provide the service about API production, FDF production, packaging.
Pharmaceutical companies are likely to outsource a wide range of manufacturing related activities including – primary and secondary packaging, formulation, active ingredient manufacturing, labeling, clinical supplies, sterilization, manufacturing of chemical intermediates, etc. CDMOs support pharmaceutical companies at all stages of the process of making medicines: by providing services in the research and development stages, by offering support in manufacturing, and by providing formulating and finishing processes.
The key service providers of the Pharmaceutical CDMO in the world are Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics and Siegfried, among which the market share of the top three service providers exceeds 10%, and Lonza is the largest service provider. The services provided by global pharmaceutical CDMO are mainly distributed in North America, Europe and China, among which the top three regions account for nearly 60% of the market share, and North America is currently the largest service provider. In terms of its service type, the growth rate of FDF CDMO is relatively fast. At present, the market share of API CDMO is the highest, more than 40%, followed by FDF CDMO, packaging CDMO and clinical CDMO. In terms of its application, pharmaceutical company are the largest application field, with a market share of more than 60%, followed by biotechnology company.
Key Features:
The report on Pharmaceutical CDMO market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pharmaceutical CDMO market. It may include historical data, market segmentation by Type (e.g., API CDMO, FDF CDMO), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pharmaceutical CDMO market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pharmaceutical CDMO market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pharmaceutical CDMO industry. This include advancements in Pharmaceutical CDMO technology, Pharmaceutical CDMO new entrants, Pharmaceutical CDMO new investment, and other innovations that are shaping the future of Pharmaceutical CDMO.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pharmaceutical CDMO market. It includes factors influencing customer ' purchasing decisions, preferences for Pharmaceutical CDMO product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pharmaceutical CDMO market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pharmaceutical CDMO market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pharmaceutical CDMO market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pharmaceutical CDMO industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pharmaceutical CDMO market.
Market Segmentation:
Pharmaceutical CDMO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- API CDMO
- FDF CDMO
- Packaging CDMO
- Clinical CDMO
- Pharmaceutical Company
- Biotechnology Company
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Catalent
- Thermo Fisher Scientific
- Samsung Biologics
- Fareva
- WuXi AppTech
- WuXi Biologics
- Siegfried
- FUJIFILM Diosynth Biotechnologies
- Asymchem
- Pfizer CentreOne
- Delpharm
- Recipharm
- AGC Pharma Chemicals
- Boehringer Ingelheim
- Vetter
- Curia
- Aenova
- Porton
- Piramal
- Strides Pharma
- NextPharma
- Famar
- Jubilant
- Alcami
- Euroapi
- Eurofins
- Avid Bioservices
- BioVectra
- CPL
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical CDMO Market Size 2019-2030
2.1.2 Pharmaceutical CDMO Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pharmaceutical CDMO Segment by Type
2.2.1 API CDMO
2.2.2 FDF CDMO
2.2.3 Packaging CDMO
2.2.4 Clinical CDMO
2.3 Pharmaceutical CDMO Market Size by Type
2.3.1 Pharmaceutical CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
2.4 Pharmaceutical CDMO Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Biotechnology Company
2.4.3 Other
2.5 Pharmaceutical CDMO Market Size by Application
2.5.1 Pharmaceutical CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
3 PHARMACEUTICAL CDMO MARKET SIZE BY PLAYER
3.1 Pharmaceutical CDMO Market Size Market Share by Players
3.1.1 Global Pharmaceutical CDMO Revenue by Players (2019-2024)
3.1.2 Global Pharmaceutical CDMO Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL CDMO BY REGIONS
4.1 Pharmaceutical CDMO Market Size by Regions (2019-2024)
4.2 Americas Pharmaceutical CDMO Market Size Growth (2019-2024)
4.3 APAC Pharmaceutical CDMO Market Size Growth (2019-2024)
4.4 Europe Pharmaceutical CDMO Market Size Growth (2019-2024)
4.5 Middle East & Africa Pharmaceutical CDMO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Pharmaceutical CDMO Market Size by Country (2019-2024)
5.2 Americas Pharmaceutical CDMO Market Size by Type (2019-2024)
5.3 Americas Pharmaceutical CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical CDMO Market Size by Region (2019-2024)
6.2 APAC Pharmaceutical CDMO Market Size by Type (2019-2024)
6.3 APAC Pharmaceutical CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical CDMO by Country (2019-2024)
7.2 Europe Pharmaceutical CDMO Market Size by Type (2019-2024)
7.3 Europe Pharmaceutical CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical CDMO by Region (2019-2024)
8.2 Middle East & Africa Pharmaceutical CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Pharmaceutical CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL CDMO MARKET FORECAST
10.1 Global Pharmaceutical CDMO Forecast by Regions (2025-2030)
10.1.1 Global Pharmaceutical CDMO Forecast by Regions (2025-2030)
10.1.2 Americas Pharmaceutical CDMO Forecast
10.1.3 APAC Pharmaceutical CDMO Forecast
10.1.4 Europe Pharmaceutical CDMO Forecast
10.1.5 Middle East & Africa Pharmaceutical CDMO Forecast
10.2 Americas Pharmaceutical CDMO Forecast by Country (2025-2030)
10.2.1 United States Pharmaceutical CDMO Market Forecast
10.2.2 Canada Pharmaceutical CDMO Market Forecast
10.2.3 Mexico Pharmaceutical CDMO Market Forecast
10.2.4 Brazil Pharmaceutical CDMO Market Forecast
10.3 APAC Pharmaceutical CDMO Forecast by Region (2025-2030)
10.3.1 China Pharmaceutical CDMO Market Forecast
10.3.2 Japan Pharmaceutical CDMO Market Forecast
10.3.3 Korea Pharmaceutical CDMO Market Forecast
10.3.4 Southeast Asia Pharmaceutical CDMO Market Forecast
10.3.5 India Pharmaceutical CDMO Market Forecast
10.3.6 Australia Pharmaceutical CDMO Market Forecast
10.4 Europe Pharmaceutical CDMO Forecast by Country (2025-2030)
10.4.1 Germany Pharmaceutical CDMO Market Forecast
10.4.2 France Pharmaceutical CDMO Market Forecast
10.4.3 UK Pharmaceutical CDMO Market Forecast
10.4.4 Italy Pharmaceutical CDMO Market Forecast
10.4.5 Russia Pharmaceutical CDMO Market Forecast
10.5 Middle East & Africa Pharmaceutical CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Pharmaceutical CDMO Market Forecast
10.5.2 South Africa Pharmaceutical CDMO Market Forecast
10.5.3 Israel Pharmaceutical CDMO Market Forecast
10.5.4 Turkey Pharmaceutical CDMO Market Forecast
10.5.5 GCC Countries Pharmaceutical CDMO Market Forecast
10.6 Global Pharmaceutical CDMO Forecast by Type (2025-2030)
10.7 Global Pharmaceutical CDMO Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Pharmaceutical CDMO Product Offered
11.1.3 Lonza Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Pharmaceutical CDMO Product Offered
11.2.3 Catalent Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Pharmaceutical CDMO Product Offered
11.3.3 Thermo Fisher Scientific Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Information
11.4.2 Samsung Biologics Pharmaceutical CDMO Product Offered
11.4.3 Samsung Biologics Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Samsung Biologics Main Business Overview
11.4.5 Samsung Biologics Latest Developments
11.5 Fareva
11.5.1 Fareva Company Information
11.5.2 Fareva Pharmaceutical CDMO Product Offered
11.5.3 Fareva Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Fareva Main Business Overview
11.5.5 Fareva Latest Developments
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Information
11.6.2 WuXi AppTech Pharmaceutical CDMO Product Offered
11.6.3 WuXi AppTech Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 WuXi AppTech Main Business Overview
11.6.5 WuXi AppTech Latest Developments
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Information
11.7.2 WuXi Biologics Pharmaceutical CDMO Product Offered
11.7.3 WuXi Biologics Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 WuXi Biologics Main Business Overview
11.7.5 WuXi Biologics Latest Developments
11.8 Siegfried
11.8.1 Siegfried Company Information
11.8.2 Siegfried Pharmaceutical CDMO Product Offered
11.8.3 Siegfried Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Siegfried Main Business Overview
11.8.5 Siegfried Latest Developments
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Information
11.9.2 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Product Offered
11.9.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.9.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.10 Asymchem
11.10.1 Asymchem Company Information
11.10.2 Asymchem Pharmaceutical CDMO Product Offered
11.10.3 Asymchem Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Asymchem Main Business Overview
11.10.5 Asymchem Latest Developments
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Information
11.11.2 Pfizer CentreOne Pharmaceutical CDMO Product Offered
11.11.3 Pfizer CentreOne Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Pfizer CentreOne Main Business Overview
11.11.5 Pfizer CentreOne Latest Developments
11.12 Delpharm
11.12.1 Delpharm Company Information
11.12.2 Delpharm Pharmaceutical CDMO Product Offered
11.12.3 Delpharm Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Delpharm Main Business Overview
11.12.5 Delpharm Latest Developments
11.13 Recipharm
11.13.1 Recipharm Company Information
11.13.2 Recipharm Pharmaceutical CDMO Product Offered
11.13.3 Recipharm Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Recipharm Main Business Overview
11.13.5 Recipharm Latest Developments
11.14 AGC Pharma Chemicals
11.14.1 AGC Pharma Chemicals Company Information
11.14.2 AGC Pharma Chemicals Pharmaceutical CDMO Product Offered
11.14.3 AGC Pharma Chemicals Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 AGC Pharma Chemicals Main Business Overview
11.14.5 AGC Pharma Chemicals Latest Developments
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Company Information
11.15.2 Boehringer Ingelheim Pharmaceutical CDMO Product Offered
11.15.3 Boehringer Ingelheim Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Boehringer Ingelheim Main Business Overview
11.15.5 Boehringer Ingelheim Latest Developments
11.16 Vetter
11.16.1 Vetter Company Information
11.16.2 Vetter Pharmaceutical CDMO Product Offered
11.16.3 Vetter Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Vetter Main Business Overview
11.16.5 Vetter Latest Developments
11.17 Curia
11.17.1 Curia Company Information
11.17.2 Curia Pharmaceutical CDMO Product Offered
11.17.3 Curia Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Curia Main Business Overview
11.17.5 Curia Latest Developments
11.18 Aenova
11.18.1 Aenova Company Information
11.18.2 Aenova Pharmaceutical CDMO Product Offered
11.18.3 Aenova Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Aenova Main Business Overview
11.18.5 Aenova Latest Developments
11.19 Porton
11.19.1 Porton Company Information
11.19.2 Porton Pharmaceutical CDMO Product Offered
11.19.3 Porton Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Porton Main Business Overview
11.19.5 Porton Latest Developments
11.20 Piramal
11.20.1 Piramal Company Information
11.20.2 Piramal Pharmaceutical CDMO Product Offered
11.20.3 Piramal Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Piramal Main Business Overview
11.20.5 Piramal Latest Developments
11.21 Strides Pharma
11.21.1 Strides Pharma Company Information
11.21.2 Strides Pharma Pharmaceutical CDMO Product Offered
11.21.3 Strides Pharma Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Strides Pharma Main Business Overview
11.21.5 Strides Pharma Latest Developments
11.22 NextPharma
11.22.1 NextPharma Company Information
11.22.2 NextPharma Pharmaceutical CDMO Product Offered
11.22.3 NextPharma Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 NextPharma Main Business Overview
11.22.5 NextPharma Latest Developments
11.23 Famar
11.23.1 Famar Company Information
11.23.2 Famar Pharmaceutical CDMO Product Offered
11.23.3 Famar Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Famar Main Business Overview
11.23.5 Famar Latest Developments
11.24 Jubilant
11.24.1 Jubilant Company Information
11.24.2 Jubilant Pharmaceutical CDMO Product Offered
11.24.3 Jubilant Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 Jubilant Main Business Overview
11.24.5 Jubilant Latest Developments
11.25 Alcami
11.25.1 Alcami Company Information
11.25.2 Alcami Pharmaceutical CDMO Product Offered
11.25.3 Alcami Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Alcami Main Business Overview
11.25.5 Alcami Latest Developments
11.26 Euroapi
11.26.1 Euroapi Company Information
11.26.2 Euroapi Pharmaceutical CDMO Product Offered
11.26.3 Euroapi Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.26.4 Euroapi Main Business Overview
11.26.5 Euroapi Latest Developments
11.27 Eurofins
11.27.1 Eurofins Company Information
11.27.2 Eurofins Pharmaceutical CDMO Product Offered
11.27.3 Eurofins Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.27.4 Eurofins Main Business Overview
11.27.5 Eurofins Latest Developments
11.28 Avid Bioservices
11.28.1 Avid Bioservices Company Information
11.28.2 Avid Bioservices Pharmaceutical CDMO Product Offered
11.28.3 Avid Bioservices Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.28.4 Avid Bioservices Main Business Overview
11.28.5 Avid Bioservices Latest Developments
11.29 BioVectra
11.29.1 BioVectra Company Information
11.29.2 BioVectra Pharmaceutical CDMO Product Offered
11.29.3 BioVectra Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.29.4 BioVectra Main Business Overview
11.29.5 BioVectra Latest Developments
11.30 CPL
11.30.1 CPL Company Information
11.30.2 CPL Pharmaceutical CDMO Product Offered
11.30.3 CPL Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.30.4 CPL Main Business Overview
11.30.5 CPL Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical CDMO Market Size 2019-2030
2.1.2 Pharmaceutical CDMO Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pharmaceutical CDMO Segment by Type
2.2.1 API CDMO
2.2.2 FDF CDMO
2.2.3 Packaging CDMO
2.2.4 Clinical CDMO
2.3 Pharmaceutical CDMO Market Size by Type
2.3.1 Pharmaceutical CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
2.4 Pharmaceutical CDMO Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Biotechnology Company
2.4.3 Other
2.5 Pharmaceutical CDMO Market Size by Application
2.5.1 Pharmaceutical CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
3 PHARMACEUTICAL CDMO MARKET SIZE BY PLAYER
3.1 Pharmaceutical CDMO Market Size Market Share by Players
3.1.1 Global Pharmaceutical CDMO Revenue by Players (2019-2024)
3.1.2 Global Pharmaceutical CDMO Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL CDMO BY REGIONS
4.1 Pharmaceutical CDMO Market Size by Regions (2019-2024)
4.2 Americas Pharmaceutical CDMO Market Size Growth (2019-2024)
4.3 APAC Pharmaceutical CDMO Market Size Growth (2019-2024)
4.4 Europe Pharmaceutical CDMO Market Size Growth (2019-2024)
4.5 Middle East & Africa Pharmaceutical CDMO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Pharmaceutical CDMO Market Size by Country (2019-2024)
5.2 Americas Pharmaceutical CDMO Market Size by Type (2019-2024)
5.3 Americas Pharmaceutical CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical CDMO Market Size by Region (2019-2024)
6.2 APAC Pharmaceutical CDMO Market Size by Type (2019-2024)
6.3 APAC Pharmaceutical CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical CDMO by Country (2019-2024)
7.2 Europe Pharmaceutical CDMO Market Size by Type (2019-2024)
7.3 Europe Pharmaceutical CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical CDMO by Region (2019-2024)
8.2 Middle East & Africa Pharmaceutical CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Pharmaceutical CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL CDMO MARKET FORECAST
10.1 Global Pharmaceutical CDMO Forecast by Regions (2025-2030)
10.1.1 Global Pharmaceutical CDMO Forecast by Regions (2025-2030)
10.1.2 Americas Pharmaceutical CDMO Forecast
10.1.3 APAC Pharmaceutical CDMO Forecast
10.1.4 Europe Pharmaceutical CDMO Forecast
10.1.5 Middle East & Africa Pharmaceutical CDMO Forecast
10.2 Americas Pharmaceutical CDMO Forecast by Country (2025-2030)
10.2.1 United States Pharmaceutical CDMO Market Forecast
10.2.2 Canada Pharmaceutical CDMO Market Forecast
10.2.3 Mexico Pharmaceutical CDMO Market Forecast
10.2.4 Brazil Pharmaceutical CDMO Market Forecast
10.3 APAC Pharmaceutical CDMO Forecast by Region (2025-2030)
10.3.1 China Pharmaceutical CDMO Market Forecast
10.3.2 Japan Pharmaceutical CDMO Market Forecast
10.3.3 Korea Pharmaceutical CDMO Market Forecast
10.3.4 Southeast Asia Pharmaceutical CDMO Market Forecast
10.3.5 India Pharmaceutical CDMO Market Forecast
10.3.6 Australia Pharmaceutical CDMO Market Forecast
10.4 Europe Pharmaceutical CDMO Forecast by Country (2025-2030)
10.4.1 Germany Pharmaceutical CDMO Market Forecast
10.4.2 France Pharmaceutical CDMO Market Forecast
10.4.3 UK Pharmaceutical CDMO Market Forecast
10.4.4 Italy Pharmaceutical CDMO Market Forecast
10.4.5 Russia Pharmaceutical CDMO Market Forecast
10.5 Middle East & Africa Pharmaceutical CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Pharmaceutical CDMO Market Forecast
10.5.2 South Africa Pharmaceutical CDMO Market Forecast
10.5.3 Israel Pharmaceutical CDMO Market Forecast
10.5.4 Turkey Pharmaceutical CDMO Market Forecast
10.5.5 GCC Countries Pharmaceutical CDMO Market Forecast
10.6 Global Pharmaceutical CDMO Forecast by Type (2025-2030)
10.7 Global Pharmaceutical CDMO Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Pharmaceutical CDMO Product Offered
11.1.3 Lonza Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Pharmaceutical CDMO Product Offered
11.2.3 Catalent Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Pharmaceutical CDMO Product Offered
11.3.3 Thermo Fisher Scientific Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Information
11.4.2 Samsung Biologics Pharmaceutical CDMO Product Offered
11.4.3 Samsung Biologics Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Samsung Biologics Main Business Overview
11.4.5 Samsung Biologics Latest Developments
11.5 Fareva
11.5.1 Fareva Company Information
11.5.2 Fareva Pharmaceutical CDMO Product Offered
11.5.3 Fareva Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Fareva Main Business Overview
11.5.5 Fareva Latest Developments
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Information
11.6.2 WuXi AppTech Pharmaceutical CDMO Product Offered
11.6.3 WuXi AppTech Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 WuXi AppTech Main Business Overview
11.6.5 WuXi AppTech Latest Developments
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Information
11.7.2 WuXi Biologics Pharmaceutical CDMO Product Offered
11.7.3 WuXi Biologics Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 WuXi Biologics Main Business Overview
11.7.5 WuXi Biologics Latest Developments
11.8 Siegfried
11.8.1 Siegfried Company Information
11.8.2 Siegfried Pharmaceutical CDMO Product Offered
11.8.3 Siegfried Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Siegfried Main Business Overview
11.8.5 Siegfried Latest Developments
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Information
11.9.2 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Product Offered
11.9.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.9.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.10 Asymchem
11.10.1 Asymchem Company Information
11.10.2 Asymchem Pharmaceutical CDMO Product Offered
11.10.3 Asymchem Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Asymchem Main Business Overview
11.10.5 Asymchem Latest Developments
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Information
11.11.2 Pfizer CentreOne Pharmaceutical CDMO Product Offered
11.11.3 Pfizer CentreOne Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Pfizer CentreOne Main Business Overview
11.11.5 Pfizer CentreOne Latest Developments
11.12 Delpharm
11.12.1 Delpharm Company Information
11.12.2 Delpharm Pharmaceutical CDMO Product Offered
11.12.3 Delpharm Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Delpharm Main Business Overview
11.12.5 Delpharm Latest Developments
11.13 Recipharm
11.13.1 Recipharm Company Information
11.13.2 Recipharm Pharmaceutical CDMO Product Offered
11.13.3 Recipharm Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Recipharm Main Business Overview
11.13.5 Recipharm Latest Developments
11.14 AGC Pharma Chemicals
11.14.1 AGC Pharma Chemicals Company Information
11.14.2 AGC Pharma Chemicals Pharmaceutical CDMO Product Offered
11.14.3 AGC Pharma Chemicals Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 AGC Pharma Chemicals Main Business Overview
11.14.5 AGC Pharma Chemicals Latest Developments
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Company Information
11.15.2 Boehringer Ingelheim Pharmaceutical CDMO Product Offered
11.15.3 Boehringer Ingelheim Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Boehringer Ingelheim Main Business Overview
11.15.5 Boehringer Ingelheim Latest Developments
11.16 Vetter
11.16.1 Vetter Company Information
11.16.2 Vetter Pharmaceutical CDMO Product Offered
11.16.3 Vetter Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Vetter Main Business Overview
11.16.5 Vetter Latest Developments
11.17 Curia
11.17.1 Curia Company Information
11.17.2 Curia Pharmaceutical CDMO Product Offered
11.17.3 Curia Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Curia Main Business Overview
11.17.5 Curia Latest Developments
11.18 Aenova
11.18.1 Aenova Company Information
11.18.2 Aenova Pharmaceutical CDMO Product Offered
11.18.3 Aenova Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Aenova Main Business Overview
11.18.5 Aenova Latest Developments
11.19 Porton
11.19.1 Porton Company Information
11.19.2 Porton Pharmaceutical CDMO Product Offered
11.19.3 Porton Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Porton Main Business Overview
11.19.5 Porton Latest Developments
11.20 Piramal
11.20.1 Piramal Company Information
11.20.2 Piramal Pharmaceutical CDMO Product Offered
11.20.3 Piramal Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Piramal Main Business Overview
11.20.5 Piramal Latest Developments
11.21 Strides Pharma
11.21.1 Strides Pharma Company Information
11.21.2 Strides Pharma Pharmaceutical CDMO Product Offered
11.21.3 Strides Pharma Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Strides Pharma Main Business Overview
11.21.5 Strides Pharma Latest Developments
11.22 NextPharma
11.22.1 NextPharma Company Information
11.22.2 NextPharma Pharmaceutical CDMO Product Offered
11.22.3 NextPharma Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 NextPharma Main Business Overview
11.22.5 NextPharma Latest Developments
11.23 Famar
11.23.1 Famar Company Information
11.23.2 Famar Pharmaceutical CDMO Product Offered
11.23.3 Famar Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Famar Main Business Overview
11.23.5 Famar Latest Developments
11.24 Jubilant
11.24.1 Jubilant Company Information
11.24.2 Jubilant Pharmaceutical CDMO Product Offered
11.24.3 Jubilant Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 Jubilant Main Business Overview
11.24.5 Jubilant Latest Developments
11.25 Alcami
11.25.1 Alcami Company Information
11.25.2 Alcami Pharmaceutical CDMO Product Offered
11.25.3 Alcami Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Alcami Main Business Overview
11.25.5 Alcami Latest Developments
11.26 Euroapi
11.26.1 Euroapi Company Information
11.26.2 Euroapi Pharmaceutical CDMO Product Offered
11.26.3 Euroapi Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.26.4 Euroapi Main Business Overview
11.26.5 Euroapi Latest Developments
11.27 Eurofins
11.27.1 Eurofins Company Information
11.27.2 Eurofins Pharmaceutical CDMO Product Offered
11.27.3 Eurofins Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.27.4 Eurofins Main Business Overview
11.27.5 Eurofins Latest Developments
11.28 Avid Bioservices
11.28.1 Avid Bioservices Company Information
11.28.2 Avid Bioservices Pharmaceutical CDMO Product Offered
11.28.3 Avid Bioservices Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.28.4 Avid Bioservices Main Business Overview
11.28.5 Avid Bioservices Latest Developments
11.29 BioVectra
11.29.1 BioVectra Company Information
11.29.2 BioVectra Pharmaceutical CDMO Product Offered
11.29.3 BioVectra Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.29.4 BioVectra Main Business Overview
11.29.5 BioVectra Latest Developments
11.30 CPL
11.30.1 CPL Company Information
11.30.2 CPL Pharmaceutical CDMO Product Offered
11.30.3 CPL Pharmaceutical CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.30.4 CPL Main Business Overview
11.30.5 CPL Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of API CDMO
Table 3. Major Players of FDF CDMO
Table 4. Major Players of Packaging CDMO
Table 5. Major Players of Clinical CDMO
Table 6. Pharmaceutical CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Pharmaceutical CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 9. Pharmaceutical CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Pharmaceutical CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 12. Global Pharmaceutical CDMO Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Pharmaceutical CDMO Revenue Market Share by Player (2019-2024)
Table 14. Pharmaceutical CDMO Key Players Head office and Products Offered
Table 15. Pharmaceutical CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmaceutical CDMO Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Pharmaceutical CDMO Market Size Market Share by Regions (2019-2024)
Table 20. Global Pharmaceutical CDMO Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Pharmaceutical CDMO Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Pharmaceutical CDMO Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Pharmaceutical CDMO Market Size Market Share by Country (2019-2024)
Table 24. Americas Pharmaceutical CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 26. Americas Pharmaceutical CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 28. APAC Pharmaceutical CDMO Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Pharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Table 30. APAC Pharmaceutical CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 32. APAC Pharmaceutical CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 34. Europe Pharmaceutical CDMO Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Pharmaceutical CDMO Market Size Market Share by Country (2019-2024)
Table 36. Europe Pharmaceutical CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 38. Europe Pharmaceutical CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Pharmaceutical CDMO Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Pharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Pharmaceutical CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Pharmaceutical CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Pharmaceutical CDMO
Table 47. Key Market Challenges & Risks of Pharmaceutical CDMO
Table 48. Key Industry Trends of Pharmaceutical CDMO
Table 49. Global Pharmaceutical CDMO Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Pharmaceutical CDMO Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Pharmaceutical CDMO Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Pharmaceutical CDMO Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Lonza Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 54. Lonza Pharmaceutical CDMO Product Offered
Table 55. Lonza Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Lonza Main Business
Table 57. Lonza Latest Developments
Table 58. Catalent Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 59. Catalent Pharmaceutical CDMO Product Offered
Table 60. Catalent Main Business
Table 61. Catalent Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Catalent Latest Developments
Table 63. Thermo Fisher Scientific Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 64. Thermo Fisher Scientific Pharmaceutical CDMO Product Offered
Table 65. Thermo Fisher Scientific Main Business
Table 66. Thermo Fisher Scientific Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Thermo Fisher Scientific Latest Developments
Table 68. Samsung Biologics Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 69. Samsung Biologics Pharmaceutical CDMO Product Offered
Table 70. Samsung Biologics Main Business
Table 71. Samsung Biologics Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Samsung Biologics Latest Developments
Table 73. Fareva Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 74. Fareva Pharmaceutical CDMO Product Offered
Table 75. Fareva Main Business
Table 76. Fareva Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Fareva Latest Developments
Table 78. WuXi AppTech Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 79. WuXi AppTech Pharmaceutical CDMO Product Offered
Table 80. WuXi AppTech Main Business
Table 81. WuXi AppTech Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. WuXi AppTech Latest Developments
Table 83. WuXi Biologics Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 84. WuXi Biologics Pharmaceutical CDMO Product Offered
Table 85. WuXi Biologics Main Business
Table 86. WuXi Biologics Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. WuXi Biologics Latest Developments
Table 88. Siegfried Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 89. Siegfried Pharmaceutical CDMO Product Offered
Table 90. Siegfried Main Business
Table 91. Siegfried Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Siegfried Latest Developments
Table 93. FUJIFILM Diosynth Biotechnologies Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 94. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Product Offered
Table 95. FUJIFILM Diosynth Biotechnologies Main Business
Table 96. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 98. Asymchem Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 99. Asymchem Pharmaceutical CDMO Product Offered
Table 100. Asymchem Main Business
Table 101. Asymchem Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Asymchem Latest Developments
Table 103. Pfizer CentreOne Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 104. Pfizer CentreOne Pharmaceutical CDMO Product Offered
Table 105. Pfizer CentreOne Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Pfizer CentreOne Main Business
Table 107. Pfizer CentreOne Latest Developments
Table 108. Delpharm Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 109. Delpharm Pharmaceutical CDMO Product Offered
Table 110. Delpharm Main Business
Table 111. Delpharm Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Delpharm Latest Developments
Table 113. Recipharm Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 114. Recipharm Pharmaceutical CDMO Product Offered
Table 115. Recipharm Main Business
Table 116. Recipharm Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Recipharm Latest Developments
Table 118. AGC Pharma Chemicals Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 119. AGC Pharma Chemicals Pharmaceutical CDMO Product Offered
Table 120. AGC Pharma Chemicals Main Business
Table 121. AGC Pharma Chemicals Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. AGC Pharma Chemicals Latest Developments
Table 123. Boehringer Ingelheim Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 124. Boehringer Ingelheim Pharmaceutical CDMO Product Offered
Table 125. Boehringer Ingelheim Main Business
Table 126. Boehringer Ingelheim Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Boehringer Ingelheim Latest Developments
Table 128. Vetter Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 129. Vetter Pharmaceutical CDMO Product Offered
Table 130. Vetter Main Business
Table 131. Vetter Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. Vetter Latest Developments
Table 133. Curia Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 134. Curia Pharmaceutical CDMO Product Offered
Table 135. Curia Main Business
Table 136. Curia Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. Curia Latest Developments
Table 138. Aenova Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 139. Aenova Pharmaceutical CDMO Product Offered
Table 140. Aenova Main Business
Table 141. Aenova Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. Aenova Latest Developments
Table 143. Porton Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 144. Porton Pharmaceutical CDMO Product Offered
Table 145. Porton Main Business
Table 146. Porton Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. Porton Latest Developments
Table 148. Piramal Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 149. Piramal Pharmaceutical CDMO Product Offered
Table 150. Piramal Main Business
Table 151. Piramal Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 152. Piramal Latest Developments
Table 153. Strides Pharma Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 154. Strides Pharma Pharmaceutical CDMO Product Offered
Table 155. Strides Pharma Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 156. Strides Pharma Main Business
Table 157. Strides Pharma Latest Developments
Table 158. NextPharma Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 159. NextPharma Pharmaceutical CDMO Product Offered
Table 160. NextPharma Main Business
Table 161. NextPharma Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 162. NextPharma Latest Developments
Table 163. Famar Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 164. Famar Pharmaceutical CDMO Product Offered
Table 165. Famar Main Business
Table 166. Famar Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 167. Famar Latest Developments
Table 168. Jubilant Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 169. Jubilant Pharmaceutical CDMO Product Offered
Table 170. Jubilant Main Business
Table 171. Jubilant Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 172. Jubilant Latest Developments
Table 173. Alcami Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 174. Alcami Pharmaceutical CDMO Product Offered
Table 175. Alcami Main Business
Table 176. Alcami Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 177. Alcami Latest Developments
Table 178. Euroapi Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 179. Euroapi Pharmaceutical CDMO Product Offered
Table 180. Euroapi Main Business
Table 181. Euroapi Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 182. Euroapi Latest Developments
Table 183. Eurofins Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 184. Eurofins Pharmaceutical CDMO Product Offered
Table 185. Eurofins Main Business
Table 186. Eurofins Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 187. Eurofins Latest Developments
Table 188. Avid Bioservices Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 189. Avid Bioservices Pharmaceutical CDMO Product Offered
Table 190. Avid Bioservices Main Business
Table 191. Avid Bioservices Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 192. Avid Bioservices Latest Developments
Table 193. BioVectra Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 194. BioVectra Pharmaceutical CDMO Product Offered
Table 195. BioVectra Main Business
Table 196. BioVectra Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 197. BioVectra Latest Developments
Table 198. CPL Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 199. CPL Pharmaceutical CDMO Product Offered
Table 200. CPL Main Business
Table 201. CPL Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 202. CPL Latest Developments
Table 1. Pharmaceutical CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of API CDMO
Table 3. Major Players of FDF CDMO
Table 4. Major Players of Packaging CDMO
Table 5. Major Players of Clinical CDMO
Table 6. Pharmaceutical CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Pharmaceutical CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 9. Pharmaceutical CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Pharmaceutical CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 12. Global Pharmaceutical CDMO Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Pharmaceutical CDMO Revenue Market Share by Player (2019-2024)
Table 14. Pharmaceutical CDMO Key Players Head office and Products Offered
Table 15. Pharmaceutical CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmaceutical CDMO Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Pharmaceutical CDMO Market Size Market Share by Regions (2019-2024)
Table 20. Global Pharmaceutical CDMO Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Pharmaceutical CDMO Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Pharmaceutical CDMO Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Pharmaceutical CDMO Market Size Market Share by Country (2019-2024)
Table 24. Americas Pharmaceutical CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 26. Americas Pharmaceutical CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 28. APAC Pharmaceutical CDMO Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Pharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Table 30. APAC Pharmaceutical CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 32. APAC Pharmaceutical CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 34. Europe Pharmaceutical CDMO Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Pharmaceutical CDMO Market Size Market Share by Country (2019-2024)
Table 36. Europe Pharmaceutical CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 38. Europe Pharmaceutical CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Pharmaceutical CDMO Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Pharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Pharmaceutical CDMO Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Pharmaceutical CDMO Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Pharmaceutical CDMO
Table 47. Key Market Challenges & Risks of Pharmaceutical CDMO
Table 48. Key Industry Trends of Pharmaceutical CDMO
Table 49. Global Pharmaceutical CDMO Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Pharmaceutical CDMO Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Pharmaceutical CDMO Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Pharmaceutical CDMO Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Lonza Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 54. Lonza Pharmaceutical CDMO Product Offered
Table 55. Lonza Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Lonza Main Business
Table 57. Lonza Latest Developments
Table 58. Catalent Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 59. Catalent Pharmaceutical CDMO Product Offered
Table 60. Catalent Main Business
Table 61. Catalent Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Catalent Latest Developments
Table 63. Thermo Fisher Scientific Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 64. Thermo Fisher Scientific Pharmaceutical CDMO Product Offered
Table 65. Thermo Fisher Scientific Main Business
Table 66. Thermo Fisher Scientific Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Thermo Fisher Scientific Latest Developments
Table 68. Samsung Biologics Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 69. Samsung Biologics Pharmaceutical CDMO Product Offered
Table 70. Samsung Biologics Main Business
Table 71. Samsung Biologics Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Samsung Biologics Latest Developments
Table 73. Fareva Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 74. Fareva Pharmaceutical CDMO Product Offered
Table 75. Fareva Main Business
Table 76. Fareva Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Fareva Latest Developments
Table 78. WuXi AppTech Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 79. WuXi AppTech Pharmaceutical CDMO Product Offered
Table 80. WuXi AppTech Main Business
Table 81. WuXi AppTech Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. WuXi AppTech Latest Developments
Table 83. WuXi Biologics Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 84. WuXi Biologics Pharmaceutical CDMO Product Offered
Table 85. WuXi Biologics Main Business
Table 86. WuXi Biologics Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. WuXi Biologics Latest Developments
Table 88. Siegfried Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 89. Siegfried Pharmaceutical CDMO Product Offered
Table 90. Siegfried Main Business
Table 91. Siegfried Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Siegfried Latest Developments
Table 93. FUJIFILM Diosynth Biotechnologies Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 94. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Product Offered
Table 95. FUJIFILM Diosynth Biotechnologies Main Business
Table 96. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 98. Asymchem Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 99. Asymchem Pharmaceutical CDMO Product Offered
Table 100. Asymchem Main Business
Table 101. Asymchem Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Asymchem Latest Developments
Table 103. Pfizer CentreOne Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 104. Pfizer CentreOne Pharmaceutical CDMO Product Offered
Table 105. Pfizer CentreOne Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Pfizer CentreOne Main Business
Table 107. Pfizer CentreOne Latest Developments
Table 108. Delpharm Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 109. Delpharm Pharmaceutical CDMO Product Offered
Table 110. Delpharm Main Business
Table 111. Delpharm Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Delpharm Latest Developments
Table 113. Recipharm Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 114. Recipharm Pharmaceutical CDMO Product Offered
Table 115. Recipharm Main Business
Table 116. Recipharm Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Recipharm Latest Developments
Table 118. AGC Pharma Chemicals Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 119. AGC Pharma Chemicals Pharmaceutical CDMO Product Offered
Table 120. AGC Pharma Chemicals Main Business
Table 121. AGC Pharma Chemicals Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. AGC Pharma Chemicals Latest Developments
Table 123. Boehringer Ingelheim Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 124. Boehringer Ingelheim Pharmaceutical CDMO Product Offered
Table 125. Boehringer Ingelheim Main Business
Table 126. Boehringer Ingelheim Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Boehringer Ingelheim Latest Developments
Table 128. Vetter Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 129. Vetter Pharmaceutical CDMO Product Offered
Table 130. Vetter Main Business
Table 131. Vetter Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. Vetter Latest Developments
Table 133. Curia Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 134. Curia Pharmaceutical CDMO Product Offered
Table 135. Curia Main Business
Table 136. Curia Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. Curia Latest Developments
Table 138. Aenova Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 139. Aenova Pharmaceutical CDMO Product Offered
Table 140. Aenova Main Business
Table 141. Aenova Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. Aenova Latest Developments
Table 143. Porton Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 144. Porton Pharmaceutical CDMO Product Offered
Table 145. Porton Main Business
Table 146. Porton Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. Porton Latest Developments
Table 148. Piramal Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 149. Piramal Pharmaceutical CDMO Product Offered
Table 150. Piramal Main Business
Table 151. Piramal Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 152. Piramal Latest Developments
Table 153. Strides Pharma Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 154. Strides Pharma Pharmaceutical CDMO Product Offered
Table 155. Strides Pharma Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 156. Strides Pharma Main Business
Table 157. Strides Pharma Latest Developments
Table 158. NextPharma Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 159. NextPharma Pharmaceutical CDMO Product Offered
Table 160. NextPharma Main Business
Table 161. NextPharma Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 162. NextPharma Latest Developments
Table 163. Famar Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 164. Famar Pharmaceutical CDMO Product Offered
Table 165. Famar Main Business
Table 166. Famar Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 167. Famar Latest Developments
Table 168. Jubilant Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 169. Jubilant Pharmaceutical CDMO Product Offered
Table 170. Jubilant Main Business
Table 171. Jubilant Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 172. Jubilant Latest Developments
Table 173. Alcami Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 174. Alcami Pharmaceutical CDMO Product Offered
Table 175. Alcami Main Business
Table 176. Alcami Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 177. Alcami Latest Developments
Table 178. Euroapi Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 179. Euroapi Pharmaceutical CDMO Product Offered
Table 180. Euroapi Main Business
Table 181. Euroapi Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 182. Euroapi Latest Developments
Table 183. Eurofins Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 184. Eurofins Pharmaceutical CDMO Product Offered
Table 185. Eurofins Main Business
Table 186. Eurofins Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 187. Eurofins Latest Developments
Table 188. Avid Bioservices Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 189. Avid Bioservices Pharmaceutical CDMO Product Offered
Table 190. Avid Bioservices Main Business
Table 191. Avid Bioservices Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 192. Avid Bioservices Latest Developments
Table 193. BioVectra Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 194. BioVectra Pharmaceutical CDMO Product Offered
Table 195. BioVectra Main Business
Table 196. BioVectra Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 197. BioVectra Latest Developments
Table 198. CPL Details, Company Type, Pharmaceutical CDMO Area Served and Its Competitors
Table 199. CPL Pharmaceutical CDMO Product Offered
Table 200. CPL Main Business
Table 201. CPL Pharmaceutical CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 202. CPL Latest Developments
LIST OF FIGURES
Figure 1. Pharmaceutical CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical CDMO Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Pharmaceutical CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pharmaceutical CDMO Sales Market Share by Country/Region (2023)
Figure 8. Pharmaceutical CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pharmaceutical CDMO Market Size Market Share by Type in 2023
Figure 10. Pharmaceutical CDMO in Pharmaceutical Company
Figure 11. Global Pharmaceutical CDMO Market: Pharmaceutical Company (2019-2024) & ($ Millions)
Figure 12. Pharmaceutical CDMO in Biotechnology Company
Figure 13. Global Pharmaceutical CDMO Market: Biotechnology Company (2019-2024) & ($ Millions)
Figure 14. Pharmaceutical CDMO in Other
Figure 15. Global Pharmaceutical CDMO Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Pharmaceutical CDMO Market Size Market Share by Application in 2023
Figure 17. Global Pharmaceutical CDMO Revenue Market Share by Player in 2023
Figure 18. Global Pharmaceutical CDMO Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Pharmaceutical CDMO Market Size 2019-2024 ($ Millions)
Figure 20. APAC Pharmaceutical CDMO Market Size 2019-2024 ($ Millions)
Figure 21. Europe Pharmaceutical CDMO Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Pharmaceutical CDMO Market Size 2019-2024 ($ Millions)
Figure 23. Americas Pharmaceutical CDMO Value Market Share by Country in 2023
Figure 24. United States Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Pharmaceutical CDMO Market Size Market Share by Region in 2023
Figure 29. APAC Pharmaceutical CDMO Market Size Market Share by Type in 2023
Figure 30. APAC Pharmaceutical CDMO Market Size Market Share by Application in 2023
Figure 31. China Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Pharmaceutical CDMO Market Size Market Share by Country in 2023
Figure 38. Europe Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Figure 39. Europe Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Figure 40. Germany Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Pharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 54. APAC Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 55. Europe Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 57. United States Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 58. Canada Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 61. China Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 62. Japan Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 63. Korea Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 65. India Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 66. Australia Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 67. Germany Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 68. France Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 69. UK Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 70. Italy Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 71. Russia Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 72. Spain Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 75. Israel Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 78. Global Pharmaceutical CDMO Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Pharmaceutical CDMO Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Pharmaceutical CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical CDMO Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Pharmaceutical CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pharmaceutical CDMO Sales Market Share by Country/Region (2023)
Figure 8. Pharmaceutical CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pharmaceutical CDMO Market Size Market Share by Type in 2023
Figure 10. Pharmaceutical CDMO in Pharmaceutical Company
Figure 11. Global Pharmaceutical CDMO Market: Pharmaceutical Company (2019-2024) & ($ Millions)
Figure 12. Pharmaceutical CDMO in Biotechnology Company
Figure 13. Global Pharmaceutical CDMO Market: Biotechnology Company (2019-2024) & ($ Millions)
Figure 14. Pharmaceutical CDMO in Other
Figure 15. Global Pharmaceutical CDMO Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Pharmaceutical CDMO Market Size Market Share by Application in 2023
Figure 17. Global Pharmaceutical CDMO Revenue Market Share by Player in 2023
Figure 18. Global Pharmaceutical CDMO Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Pharmaceutical CDMO Market Size 2019-2024 ($ Millions)
Figure 20. APAC Pharmaceutical CDMO Market Size 2019-2024 ($ Millions)
Figure 21. Europe Pharmaceutical CDMO Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Pharmaceutical CDMO Market Size 2019-2024 ($ Millions)
Figure 23. Americas Pharmaceutical CDMO Value Market Share by Country in 2023
Figure 24. United States Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Pharmaceutical CDMO Market Size Market Share by Region in 2023
Figure 29. APAC Pharmaceutical CDMO Market Size Market Share by Type in 2023
Figure 30. APAC Pharmaceutical CDMO Market Size Market Share by Application in 2023
Figure 31. China Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Pharmaceutical CDMO Market Size Market Share by Country in 2023
Figure 38. Europe Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Figure 39. Europe Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Figure 40. Germany Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Pharmaceutical CDMO Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Pharmaceutical CDMO Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Pharmaceutical CDMO Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Pharmaceutical CDMO Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 54. APAC Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 55. Europe Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 57. United States Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 58. Canada Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 61. China Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 62. Japan Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 63. Korea Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 65. India Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 66. Australia Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 67. Germany Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 68. France Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 69. UK Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 70. Italy Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 71. Russia Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 72. Spain Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 75. Israel Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Pharmaceutical CDMO Market Size 2025-2030 ($ Millions)
Figure 78. Global Pharmaceutical CDMO Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Pharmaceutical CDMO Market Size Market Share Forecast by Application (2025-2030)
